过度饮酒会急性诱导易于逆转的肝硬化症:在健康成年人身上进行的一项现实观察性研究
Kristoffer Kjærgaard1,2, Jeppe Mygind Yeoman1, Peter Lykke Eriksen1
1Department of Hepatology and Gastroenterology, Aarhus University Hospital, Denmark.
JHEP reports : innovation in hepatology
|December 16, 2025
概括
在健康的成年人中,连续三天的过度饮酒显著增加了肝脏脂肪和硬度. 这些酒精诱导的肝脏变化在禁酒10天后完全逆转,显示急性影响的可逆性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 酒精性肝脏疾病 酒精性肝脏疾病
- 代谢功能障碍 代谢功能障碍
背景情况:
- 过度饮酒是一种普遍的,有害的饮酒模式.
- 过度饮酒对肝脏的直接影响尚不清楚.
- 了解过度饮酒导致的急性肝损伤至关重要.
研究的目的:
- 调查过度饮酒对肝脏脂肪和硬度的急性影响.
- 评估这些酒精诱导的肝脏变化的可逆性.
- 检查对健康个体的影响.
主要方法:
- 在为期3天的节日之前,期间和之后,健康的成年人接受了肝脏MRI和弹性图像.
- 酒精和食物摄入量是自我报告的;测量血液中酒精度.
- 分析了肝脏脂肪分数,肝硬度和血液标记物.
主要成果:
- 三天过度饮酒使肝脏脂肪分数增加了2.5倍 (1.9%至4.6%).
- 40%的参与者患有肥胖症;肝硬度和甘油三也增加了.
- 所有测量的肝脏参数在禁欲10天后正常化.
结论:
- 娱乐性暴饮暴酒急性诱导肝脏肥胖症和硬.
- 这些与酒精有关的肝脏变化在短期戒酒后是可逆的.
- 研究结果强调了暴饮暴饮对肝脏健康的影响.
相关概念视频
Binge Eating Disorders
402
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
402
Bioavailability Study Design: Healthy Subjects Versus Patients
133
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
133
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
236
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
236
Acute Pancreatitis I: Introduction
1.1K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.1K


